Want to see IN:MANKIND full AI Analyst Report?
Mankind Pharma Ltd. (MANKIND) Revenue
Mankind Pharma Ltd. Revenue
Mankind Pharma Ltd. had a revenue of 43.38B in the quarter ending Sep 30, 2026, with 7.62%. This bring the company's revenue in the last twelve months to 153.79B, Increased 4.35%. In the fiscal year ending Mar 31, 2026, Mankind Pharma Ltd. had annual revenue of 142.78B with 16.96% growth.
- Revenue (ttm)
- 153.79B
- Revenue Growth
- 13.27%
- P/S Ratio
- 7.20
- Revenue/Employee
- INR 6,981,390
- Employees
- 20,451
- Market Cap
- INR 1.03T
Revenue Chart
Mankind Pharma Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 142.78B | 20.70B | 16.96% |
| Mar 31, 2025 | 122.07B | 19.48B | 18.99% |
| Mar 31, 2024 | 102.59B | 15.10B | 17.26% |
| Mar 31, 2023 | 87.49B | 9.68B | 12.44% |
| Mar 31, 2022 | 77.82B | 15.67B | 25.22% |
| Mar 31, 2021 | 62.14B | 3.49B | 5.95% |
| Mar 31, 2020 | 58.65B | 8.85B | 17.78% |
| Mar 31, 2019 | 49.80B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:MANKIND | 153.79B |
| IN:ALKEM | 150.81B |
| IN:LUPIN | 299.00B |
| IN:SUNPHARMA | 599.11B |
| IN:TORNTPHARM | 156.15B |
| IN:ZYDUSLIFE | 285.92B |